Tweetovi
- Tweetovi, trenutna stranica.
- Tweetovi i odgovori
- Medijski sadržaj
Blokirali ste korisnika/cu @ARD_BMJ
Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @ARD_BMJ
-
We're delighted to announce that RMD Open has been accepted for indexing by MEDLINE! Congratulations to the editorial team and thanks to our authors and reviewers for the high quality of published articles. Discover all content at https://www.ncbi.nlm.nih.gov/pmc/journals/2836/ …pic.twitter.com/iSVAjvt6FD
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
If you haven’t had a chance to read the
@eular_org#recommendations - 2019 update - for the management of#rheumatoidarthritis take a moment to do so now: https://ard.bmj.com/content/early/2020/01/22/annrheumdis-2019-216655 …pic.twitter.com/82mVCOKmBZ
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
VEDERA trial: Compared with
#remission rates reported with 1st-line TNFi+MTX vs MTX-T2T no larger effect seen in very#ERA. Neither strategy conferred remission in the majority of patients although#ultrasound confirmed local#inflammation suppression.https://ard.bmj.com/content/early/2020/01/29/annrheumdis-2019-216539 …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Pragmatic RCT of early etanercept and MTX vs. MTX with delayed etanercept in
#rheumatoidarthritis: the VEDERA trial shows some clinically relevant differences (14%), but not a large effect size in with early etanercept (30%) http://ow.ly/Btaz30qdFZs@LeedsBRC@UoMMskResearchpic.twitter.com/ck4lnuqWq1
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Don’t forget to submit your
#EULAR2020 abstracts before the 31st of Jan deadline! Accepted abstracts are published in a special ARD supplement. Keep up to date with the latest Annual@eular_org annual congress news here https://www.congress.eular.orgHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Check our podcast on one of the highlights from
#ACR19: results of next promising new treatments in#psoriaticarthritis &#spondyloarthritis with@Stiddyo & Dr Atul Deodharhttps://soundcloud.com/bmjpodcasts/acr-paul-studenic-and-atul-deodha?in=bmjpodcasts/sets/ard-podcast …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Re-defining axial
#spondyloarthritis using a latent class/ transition analysis approach. Of the 3 entities identified, a large % of those 'at risk' never develop the disease at 5-years. Important implications to prevent overdiagnosis@AlexSepriano http://ow.ly/mNgK30qcpi3 pic.twitter.com/0n0k7vSWRB
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
New
@eular_org recommendations for the management of#rheumatoidarthritis with disease-modifying antirheumatic drugs: 2019 update http://ow.ly/KHKM30qcpaF pic.twitter.com/5qnxJhghR1
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
We're delighted that RMD Open is now indexed by MEDLINE! (NLM ID: 101662038) Congratulations to the editorial team and thanks to our authors and reviewers for helping us to publish high quality content. Explore the content archive at https://www.ncbi.nlm.nih.gov/pmc/journals/2836/ …pic.twitter.com/6Nuek6R0D6
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Long-term follow-up after cessation of immune checkpoint inhibitors (ICI) reveals that ICI-induced inflammatory arthritis persists to be active up to 24 months. Full paper here
https://ard.bmj.com/content/early/2020/01/10/annrheumdis-2019-216109 …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Lay summary: Risk of joint surgery is increased in people with psoriatic arthritis https://ift.tt/36CWgeW
#LaySummaryHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Lay summary: Standardisation is needed for sick leave and disability rules for people with RA https://ift.tt/2QXuymo
#LaySummaryHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Lay summary: TNF inhibitors can be used after JAK inhibitors https://ift.tt/36H4V01
#LaySummaryHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Lay summary: ANA status is a critical first step for diagnosing Lupus https://ift.tt/2TeFoY3
#LaySummaryHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Lay summary: Link between fatigue and brain-reacting autoantibodies in Lupus https://ift.tt/2ThvmFs
#LaySummaryHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Lay summary: Quality of life is dependent on treatment of both joint and skin symptoms in PsA https://ift.tt/36MSGza
#LaySummaryHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Listen to our new podcast from the
#ACR2019 with Eric Morand about#Anifrolumab in#SLE - the#TULIP-2 study - whilst preparing for the turn of the year.
To #podcast: http://ow.ly/kAB430q5TsJ To the paper:https://www.nejm.org/doi/full/10.1056/NEJMoa1912196 …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Germline genetic patterns underlying across familial
#rheumatoid#arthritis, systemic#lupus erythematosus and primary#Sjögren’s syndrome highlight T cell-initiated#autoimmunity http://ow.ly/jQ4O50xIh1U pic.twitter.com/OHPcgpd3GY
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Single-cell RNA-seq analysis identifies meniscus progenitors and reveals the progression of meniscus degeneration. CD146+ meniscus cells have potential in meniscus tissue engineering
#osteoarthritis http://ow.ly/HYY550xIgTq pic.twitter.com/IuHelb49Mx
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
IFN-alpha kinoid significantly reduced the IFN gene signature in
#lupus patients. The clinical coprimary endpoint was not met, but some secondary endpoints were achieved, notably attainment of LLDAS and steroid tapering. http://ow.ly/PJSK50xIgND pic.twitter.com/fZmnj5Wh1s
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi
Čini se da učitavanje traje već neko vrijeme.
Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.